Clinical Trial Update: Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Therapy-resistant CVU (Phase III) [Phase 3]

View source ↗

Summary

Phase III trial evaluating allogeneic ABCB5-positive dermal mesenchymal stromal cells for therapy-resistant chronic venous ulcers; the study is currently active…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Leg Ulcer
• Venous Ulcer

Drugs mentioned

• Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells (ABCB5-positive dermal mesenchymal stromal cells)

Snippet

Sponsor: RHEACELL GmbH & Co. KG | Conditions: Venous Leg Ulcer | Phase 3 | Status: ACTIVE_NOT_RECRUITING